학술논문
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype
Document Type
Article
Author
Source
In: Journal of Allergy and Clinical Immunology: In Practice . (Journal of Allergy and Clinical Immunology: In Practice, November 2022, 10(11):2916-2924.e4)
Subject
Language
English
ISSN
22132198